Clinical Trial: A Phase Ib Trial of Azacitidine, Venetoclax and Allogeneic NK Cells for Acute Myeloid Leukemia (ADVENT-AML)
Study Status: Completed
Recruit Status: RECRUITING
Condition: Acute Myeloid Leukemia
Study Type: INTERVENTIONAL
Official Title: A Phase Ib Trial of Azacitidine, Venetoclax and Allogeneic NK Cells for Acute Myeloid Leukemia (ADVENT-AML)
Brief Summary:
To learn if adding a healthy person's natural killer (NK) cells to the combination of Azacitidine and Venetoclax can help to control AML.NK cells are cancer- and infection-fighting immune cells.
Read more